Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

Listening...

Categories
Dates
Types
  • Mary C. Beckerle, Ph.D.

    Independent Director since 2015
  • Joseph J. Wolk

    Joseph J. Wolk (Joe) is the Executive Vice President and Chief Financial Officer for Johnson & Johnson. Joe serves as a member of the company’s Executive Committee, playing a strategic role in the overall management of the organization and leading the development and execution of the business’ global long-term financial strategy. Additionally, as the financial steward of Johnson & Johnson, Joe’s scope of responsibilities includes driving competitive and profitable growth, generating sustainable cash flow, allocating capital to maximize value creation and managing risk across the entire enterprise.
  • Kathryn E. Wengel

    Kathryn E. Wengel (Kathy) is Executive Vice President, Chief Technical Operations & Risk Officer for Johnson & Johnson, and a member of the Company’s Executive Committee. She has significant healthcare, operations and global business expertise – with more than three decades of experience in leadership positions at Johnson & Johnson.
  • Jennifer L. Taubert

    Jennifer L. Taubert is Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson, the world’s largest healthcare company. She is a member of the Corporation’s Executive Committee and leads the Innovative Medicine Group Operating Committee.
  • James Swanson

    Jim Swanson is a global business and technology leader and Executive Vice President, Chief Information Officer, and member of the Executive Committee for Johnson & Johnson.
  • John C. Reed, M.D., Ph.D.

    John C. Reed, M.D., Ph.D. is Executive Vice President, Pharmaceuticals, R&D and Johnson & Johnson (J&J) Executive Committee member, John believes there is no limit to what science can do to advance medicine and restore health.
  • Elizabeth Forminard

    Liz Forminard serves as legal advisor to the Johnson & Johnson Board of Directors and company executives and is responsible for shaping legal strategy worldwide.
  • Joaquin Duato

    As CEO of the world’s largest healthcare company, Joaquin Duato leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health.
  • Vanessa Broadhurst

    Vanessa Broadhurst is Executive Vice President, Global Corporate Affairs of Johnson & Johnson and a member of the Company’s Executive Committee. Vanessa leads the Corporation’s global marketing, communication, design and philanthropy functions, in addition to oversight of J&J Health & Wellness Solutions.